» Articles » PMID: 34366336

Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2021 Aug 9
PMID 34366336
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alzheimer's disease (AD) is characterized by cognitive impairment and large loss of grey matter volume and is the most prevalent form of dementia worldwide. Mild cognitive impairment (MCI) is the stage that precedes the AD dementia stage, but individuals with MCI do not always convert to the AD dementia stage, and it remains unclear why.

Objective: We aimed to assess grey matter loss across the brain at different stages of the clinical continuum of AD to gain a better understanding of disease progression.

Methods: In this large-cohort study (N = 1,386) using neuroimaging data from the Alzheimer's Disease Neuroimaging Initiative, voxel-based morphometry analyses were performed between healthy controls, individuals with early and late and AD dementia stage.

Results: Clear patterns of grey matter loss in mostly hippocampal and temporal regions were found across clinical stages, though not yet in early MCI. In contrast, thalamic volume loss seems one of the first signs of cognitive decline already during early MCI, whereas this volume loss does not further progress from late MCI to AD dementia stage. AD dementia stage converters already show grey matter loss in hippocampal and mid-temporal areas as well as the posterior thalamus (pulvinar) and angular gyrus at baseline.

Conclusion: This study confirms the role of temporal brain regions in AD development and suggests additional involvement of the thalamus/pulvinar and angular gyrus that may be linked to visuospatial, attentional, and memory related problems in both early MCI and AD dementia stage conversion.

Citing Articles

Association of corneal endothelial cell morphology with neurodegeneration in mild cognitive impairment and dementia.

Ponirakis G, Hamad H, Al-Waisy A, Petropoulos I, Khan A, Gad H Alzheimers Dement (N Y). 2025; 11(1):e70025.

PMID: 39759948 PMC: 11696023. DOI: 10.1002/trc2.70025.


A fusion analytic framework for investigating functional brain connectivity differences using resting-state fMRI.

Jeon Y, Kim J, Yu S, Choi J, Han S Front Neurosci. 2024; 18:1402657.

PMID: 39723421 PMC: 11668745. DOI: 10.3389/fnins.2024.1402657.


Magnesium (Mg) and Neurodegeneration: A Comprehensive Overview of Studies on Mg Levels in Biological Specimens in Humans Affected Some Neurodegenerative Disorders with an Update on Therapy and Clinical Trials Supplemented with Selected Animal Studies.

Scibior A, Llopis J, Dobrakowski P, Mecik-Kronenberg T Int J Mol Sci. 2024; 25(23).

PMID: 39684308 PMC: 11641227. DOI: 10.3390/ijms252312595.


Cortical Gray Matter Volume Associations with Dietary Fiber and Calorie Density: A Pilot Study.

Pallapothu R, Newman-Norlund R, Gibson M, Kannan P, Rorden C, Bonilha L Res Sq. 2024; .

PMID: 39649156 PMC: 11623756. DOI: 10.21203/rs.3.rs-5338934/v1.


A comparative meta-analysis of structural magnetic resonance imaging studies and gene expression profiles revealing the similarities and differences between late life depression and mild cognitive impairment.

Zhao L, Niu L, Dai H, Lee T, Huang R, Zhang R Psychol Med. 2024; :1-10.

PMID: 39582389 PMC: 11650184. DOI: 10.1017/S0033291724002563.


References
1.
Stoodley C, Schmahmann J . Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex. 2010; 46(7):831-44. PMC: 2873095. DOI: 10.1016/j.cortex.2009.11.008. View

2.
Vemuri P, Weigand S, Knopman D, Kantarci K, Boeve B, Petersen R . Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. Neuroimage. 2010; 54(2):985-91. PMC: 2997139. DOI: 10.1016/j.neuroimage.2010.09.004. View

3.
Saalmann Y, Kastner S . Cognitive and perceptual functions of the visual thalamus. Neuron. 2011; 71(2):209-23. PMC: 3148184. DOI: 10.1016/j.neuron.2011.06.027. View

4.
Cornutiu G . The Epidemiological Scale of Alzheimer's Disease. J Clin Med Res. 2015; 7(9):657-66. PMC: 4522981. DOI: 10.14740/jocmr2106w. View

5.
Benarroch E . Pulvinar: associative role in cortical function and clinical correlations. Neurology. 2015; 84(7):738-47. DOI: 10.1212/WNL.0000000000001276. View